Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study)

Michel P. Hermans,Luc Van Gaal, Ingrid Rézette,Evis Daci,Karen MacDonald,Kris Denhaerynck,Stefaan Vancayzeele, Lut De Meester,Andreas Clemens,Brian Yee,Ivo Abraham

Primary Care Diabetes（2016）

引用 7|浏览10

暂无评分

摘要

•Guidelines advocate a patient-centered approach to the management of hyperglycemia.•Patient engagement is a responsibility of both clinicians and patients.•Vildagliptin regimens improve glycemic outcomes in real-world clinical practice.•Several patient engagement activities are determinants of glycemic outcomes.•Clinicians need to engage patients and patients need to engage themselves.

查看译文

关键词

Type 2 diabetes mellitus,Diabetes mellitus,Vildagliptin,Dipeptidyl peptidase-4 inhibitor,Outcomes,Effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要